Merck and Ridgeback’s Antiviral Molnupiravir trial
News Release: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent…
Pharmacy/Drugs
Monash University: Drug repurposing is no panacea in race to treat COVID-19
Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls…
Common antibiotic reduces low birth weight and prematurity
A common antibiotic has been found to reduce low birth weight and premature births, if taken during pregnancy, in countries…
Increase in use of opioids during pandemic
The use of opioids for pain relief in patients awaiting hip and knee replacement surgery increased dramatically during the pandemic according to new research from…
Childhood trauma can make people like morphine more
People who experienced childhood trauma get a more pleasurable ‘high’ from morphine, new research suggests. Dr Molly Carlyle from The…
University wins huge grant to train pharmacists in the North
University wins huge grant to train pharmacists in the North: From September, the University of Bradford will begin training hundreds…
Vaccine supports immune response in immunosuppressed
Research from MedUni Vienna demonstrates that SARS-CoV-2 vaccination supports immune response in immunosuppressed patients Patients under immunosuppressive therapy can still…
Nasal spray tech to deliver psychedelic and non-psychedelic drugs
A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disorders will enter…
Palliative Medicine support for families
Palliative Medicine support for families: Families who are caring for a relative who is seriously ill and dying at home need…
New generation anti-cancer drug
New generation anti-cancer drug shows promise for children with brain tumours. A genetic map of an aggressive childhood brain tumour…